"Ozempic face" describes the gaunt, hollowed, or prematurely aged facial appearance some patients develop after significant weight loss on a GLP-1 medication. Despite the name, it isn't caused by semaglutide, tirzepatide, or any GLP-1 medication specifically — it's a consequence of rapid, substantial fat loss in general, which can happen with any weight loss method fast enough to outpace the skin's ability to adjust.

Why it happens?

When the body is in a significant calorie deficit, it draws down fat stores throughout the entire body, including the subcutaneous fat pads in the face that contribute to a smooth, youthful contour. Because GLP-1 medications can produce faster and more substantial weight loss than many traditional methods — often in the range of 15 to 20 percent of body weight over roughly a year and a half — facial fat can be lost faster than the skin can tighten and adjust, resulting in a more hollowed, aged appearance even in patients who are otherwise thrilled with their results.

Who's at higher risk?

Patients who lose weight especially quickly, who start treatment with less facial fat to begin with, or who are older and already have somewhat reduced skin elasticity tend to notice more pronounced facial volume changes. The total amount of weight lost and the speed at which it comes off both matter more than which specific GLP-1 medication is used.

What evidence-based prevention strategies work?

  • Prioritize protein intake throughout treatment to help preserve overall tissue, including supporting skin structure.
  • Where possible, avoid the fastest end of the weight loss range, since a slightly more gradual pace gives skin more time to adjust; this is a conversation to have with your prescribing provider around dosing and titration.
  • Stay well hydrated, since dehydration can worsen the appearance of facial hollowness.
  • Use a consistent skincare routine that supports collagen, including a retinoid and a stabilized vitamin C serum, which can help skin firmness respond better as volume shifts.
  • Maintain regular strength training, which supports overall tissue quality even though it can't directly rebuild facial fat.

What treatment options exist if facial volume loss has already occurred?

For patients who have already lost significant facial volume, dermal fillers are the most direct option, restoring lost volume in the cheeks, temples, and under-eyes with an in-office treatment that requires no downtime and produces immediate, visible results. Biostimulatory options like Sculptra or Radiesse can add a longer-term collagen-building benefit alongside volume restoration. For patients with more significant skin laxity in addition to volume loss, combining filler with a skin-tightening treatment often produces the most complete improvement.

What's the bigger picture?

Facial volume changes are a cosmetic side effect of an otherwise health-promoting process, not a reason to avoid GLP-1 treatment if it's right for you. The most effective approach is prevention from day one — protein, hydration, and a supportive skincare routine — rather than waiting to address volume loss after it's already occurred.

1. A 2024 survey by the American Society of Dermatologic Surgery found that 58% of member practitioners reported treating patients seeking facial volume restoration specifically after GLP-1 medication use — reflecting just how common this effect has become as these medications have grown in popularity.
Individual risk and results vary. This article is educational and does not replace individualized guidance from your prescribing provider and aesthetic team.